E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/22/2021 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse sells $500,000 contingent coupon autocallable yield notes on Biogen, Viatris

By Taylor Fox

New York, Feb. 22 – Credit Suisse AG, London Branch priced $500,000 of contingent coupon autocallable yield notes due Aug. 16, 2023 linked to the least performing of the common stocks of Biogen Inc. and Viatris Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a quarterly coupon at an annualized rate of 17.75% if each stock closes at or above its coupon barrier price, 70% of its initial price, on the related observation date.

The notes will be called at par plus the coupon due if both stocks close at or above 90% of their initial prices on any quarterly observation date.

The payout at maturity will be par unless any stock finishes below its knock-in price, 70% of its initial price, in which case investors will be fully exposed to the decline of the least-performing stock.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:Credit Suisse AG, London Branch
Issue:Contingent coupon autocallable yield notes
Underlying stocks:Biogen Inc. and Viatris Inc.
Amount:$500,000
Maturity:Aug. 16, 2023
Coupon:17.75% per year, payable quarterly if each stock closes at or above its coupon barrier price on the related observation date
Price:Par
Payout at maturity:Par plus any coupon due unless any stock finishes below its knock-in price, in which case full exposure to decline of least-performing stock
Call:At par plus the coupon due if both stocks close at or above 90% of their initial prices on any quarterly observation date
Initial prices:$275 for Biogen and $18.39 for Viatris
Knock-in prices:$192.5 for Biogen and $12.873 for Viatris; 70% of initial prices
Coupon barrier prices:$192.5 for Biogen and $12.873 for Viatris; 70% of initial prices
Pricing date:Feb. 10
Settlement date:Feb. 16
Agent:Credit Suisse Securities (USA) LLC
Fees:3.25%
Cusip:22552XBV4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.